Myocardial work across different etiologies of right ventricular dysfunction and healthy controls
Kristoffer Berg‐Hansen(Aarhus University), Roni Nielsen(Aarhus University), Mads J. Andersen(Aarhus University Hospital), Steen Hvitfeldt Poulsen(Aarhus University Hospital), Nigopan Gopalasingam(Aarhus University Hospital), Jesper K. Jensen(Aarhus University Hospital), Søren Mellemkjær(Aarhus University Hospital), Tor Skibsted Clemmensen(Aarhus University Hospital)
Cited by 18
Related Papers
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|526
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2024|453
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410
Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
|Journal of the American Heart Association|2017|235